Viewing Study NCT01512108


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-02-03 @ 7:30 AM
Study NCT ID: NCT01512108
Status: COMPLETED
Last Update Posted: 2017-12-18
First Post: 2012-01-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetes Mellitus, Type 2 View
Keywords: